Showing results (61-70 of 78) with videos related to
Sort By:
Pageof 8
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 22, 2007
Phase I trial of histone deacetylase inhibition by valproic acid followed by the topoisomerase II inhibitor epirubicin in advanced solid tumors: a clinical and translational studyPamela Münster, Douglas Marchion, Elona Bicaku, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 10, 2010
Phase I/II study of the Src inhibitor dasatinib in combination with erlotinib in advanced non-small-cell lung cancerEric B Haura, Tawee Tanvetyanon, Alberto Chiappori, et al.Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology|July 19, 2025
Economic burden borne by patients due to diagnostic delays in inflammatory bowel disease: Insights from a survey of newly diagnosed patientsVijesh V S, Noble Varghese Mathews, Nicholas Vijay Rao, et al.Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology|January 18, 2025
The effectiveness of a conservative approach in the management of groove pancreatitisAjith Thomas, Anand Vimal Dev, Anoop John, et al.Journal of Thoracic Disease|December 13, 2023
Osimertinib vs. afatinib as first-line treatment for patients with metastatic non-small cell lung cancer with an EGFR exon 19 deletion or exon 21 L858R mutationSophia Gilardone, Ram Thapa, José Laborde, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 12, 2011
A phase 1 dose escalation, pharmacokinetic, and pharmacodynamic evaluation of eIF-4E antisense oligonucleotide LY2275796 in patients with advanced cancerDavid S Hong, Razelle Kurzrock, Yun Oh, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2008
Phase I/II study of atrasentan, an endothelin A receptor antagonist, in combination with paclitaxel and carboplatin as first-line therapy in advanced non-small cell lung cancerAlberto A Chiappori, Eric Haura, Francisco A Rodriguez, et al.Digestive Diseases and Sciences|August 16, 2018
A Simple Pre-endoscopy Score for Predicting Risk of Malignancy in Patients with Dyspepsia: A 5-Year Prospective StudyAmit Kumar Dutta, Grace Rebekah, Sudipta Dhar Chowdhury, et al.Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|July 3, 2024
Imbalance in the vWF - ADAMTS13 axis exists early in acute pancreatitis and predicts persistent organ failure and pancreatic necrosis-a prospective studyP S Sairam, Sudipta Dhar Chowdhury, Ajith Thomas, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 23, 2014
VEGF/VEGFR-2 upregulates EZH2 expression in lung adenocarcinoma cells and EZH2 depletion enhances the response to platinum-based and VEGFR-2-targeted therapyErick Riquelme, Milind Suraokar, Carmen Behrens, et al.Pageof 8